Loading organizations...
Loading organizations...
Biotech company developing therapies for autoimmune and allergic diseases.
Apitope has raised $13.5M across 1 funding round.
Apitope has raised $13.5M in total across 1 funding round.
Apitope has raised $13.5M in total across 1 funding round.
Apitope's investors include Brenig Preest, LRM, PMV, Vesalius Biocapital, Wyvern.
Apitope has raised $13.5M across 1 funding round. Most recently, it raised $13.5M Series B in September 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 29, 2015 | $13.5M Series B | Brenig Preest | LRM, PMV, Vesalius Biocapital, Wyvern |